False-positive stereotactic vacuum-assisted breast biopsies (SVABs) may not negatively affect subsequent mammographic screenings, according to a recent study published in the Journal of the American College of Radiology (JACR). The harms of false-positives, according to reserachers from the Center for Biomedical Imaging at New York University School of Medicine, may be exaggerated.